Verrica Pharmaceuticals Inc.
NASDAQ:VRCA
0.6997 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 5.124 | 9.032 | 12 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.746 | 0.725 | 0.472 | 0.229 | 0.257 | 0.02 | 0 | 0 |
| Gross Profit
| 4.378 | 8.307 | 11.528 | -0.229 | -0.257 | -0.02 | 0 | 0 |
| Gross Profit Ratio
| 0.854 | 0.92 | 0.961 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 20.295 | 12.198 | 15.929 | 15.673 | 15.436 | 12.826 | 3.73 | 1.709 |
| General & Administrative Expenses
| 0 | 17.405 | 26.979 | 24.508 | 14.644 | 9.052 | 0.727 | 0.204 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 47.305 | 17.405 | 26.979 | 24.508 | 14.644 | 9.052 | 0.727 | 0.204 |
| Other Expenses
| 2.537 | -0.058 | 0 | -0.001 | 1.873 | -0.001 | 0 | 0 |
| Operating Expenses
| 70.137 | 29.603 | 42.908 | 40.181 | 30.08 | 21.878 | 4.457 | 1.913 |
| Operating Income
| -65.759 | -21.296 | -30.908 | -40.181 | -30.08 | -21.878 | -4.457 | -1.913 |
| Operating Income Ratio
| -12.834 | -2.358 | -2.576 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.236 | -3.191 | -4.172 | -2.513 | 1.873 | 1.23 | -0.002 | 0 |
| Income Before Tax
| -66.995 | -24.487 | -35.08 | -42.694 | -28.207 | -20.648 | -4.459 | -1.913 |
| Income Before Tax Ratio
| -13.075 | -2.711 | -2.923 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 3.191 | 3.823 | 2.803 | -0.257 | 1.23 | -4.457 | -1.913 |
| Net Income
| -66.995 | -27.678 | -38.903 | -45.497 | -27.95 | -20.648 | -4.459 | -1.913 |
| Net Income Ratio
| -13.075 | -3.064 | -3.242 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.48 | -0.81 | -1.44 | -1.82 | -1.12 | -1.41 | -0.22 | -0.096 |
| EPS Diluted
| -1.48 | -0.81 | -1.44 | -1.82 | -1.12 | -1.41 | -0.22 | -0.096 |
| EBITDA
| -62.197 | -21.597 | -30.313 | -39.432 | -30.08 | -20.628 | -4.457 | -1.913 |
| EBITDA Ratio
| -12.138 | -2.312 | -2.565 | 0 | 0 | 0 | 0 | 0 |